PD-L1 is the primary PD-1 ligand that is up-regulated in solid tumors, whereit can inhibit cytokine production and the cytolytic activity of PD-1+tumor-infiltrating CD4+ and CD8+ T cells [15,16]. The gene discussed is CD8A; the disease is neoplasm.